Clinical Study of a Novel Oncolytic Virus Ad-TD-nsIL12 in the Treatment of Primary High-grade Glioma
Clinical trial NCT07126990 · ENROLLING_BY_INVITATION
Trial details
- NCT number
- NCT07126990
- Sponsor
- Xiaorong Wu
- Status
- ENROLLING_BY_INVITATION
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-02-12
- Primary completion
- 2028-08-30
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.